• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Nature of atherosclerosis from plaque initiation to thrombosis

, 26 August 2020/in E-News /by 3wmedia

For the first time, researchers can provide early detection of plaques that have a high likelihood of clotting and/or rupture. Boston University School of Medicine (BUSM) scientists have observed the development and evolution of atherosclerotic plaques at the highest risk for thrombosis (clotting) by using non-invasive Magnetic Resonance Imaging (MRI).

Atherosclerosis is an important contributor to heart attacks and strokes, the leading causes of death in developed nations despite progress in their prevention. Atherosclerosis is a complex disease with many stages, ranging from plaques that can remain clinically silent for decades (‘stable’) to dangerous (‘vulnerable’) plaques that in their most highly advanced stage (‘highest risk’) can suddenly form a blood clot (thrombus) in the vessel, leading to myocardial infarction or stroke.

Researchers at BUSM, under the direction of James A. Hamilton, PhD, Professor of Physiology and Biophysics and Research Professor of medicine at BUSM, pioneered the use of MRI to identify high-risk plaques in a unique experimental model encompassing both atherosclerosis and thrombosis (atherothrombosis). The group established criteria for distinguishing vulnerable and stable plaques from analysis of in vivo (from a living organism) images of mature plaques. The plaques were then tested to determine their stability.

In the new study, images were obtained at monthly intervals to provide information about the pathways of progression (plaque history) of individual plaques in the vessel and to determine whether MRI can discriminate vulnerable and stable plaques at early times.

‘Vulnerable plaques and stable plaques showed different physiological progression patterns beginning after one month. Stable plaques exhibited no features of vulnerability at any time, whereas vulnerable plaques showed a progression of vulnerable features, especially in the last month,’ explained Hamilton, who is the corresponding author.

According to Hamilton, successive MRIs could provide a non-invasive means of identifying plaques that are evolving to become a high risk for rupture. ‘This work provides us a unique model for evaluating potential therapies after vulnerable plaques are clearly established.’ EurekAlert

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:48Nature of atherosclerosis from plaque initiation to thrombosis

MEDICAL FAIR ASIA 2016 preview

, 26 August 2020/in E-News /by 3wmedia

Singapore will once again play host to MEDICAL FAIR ASIA as it makes a much-anticipated return from 31 August to 2 September 2016 at a new venue

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:32MEDICAL FAIR ASIA 2016 preview

Traditional skin tests used to predict allergies to antibiotics are useless

, 26 August 2020/in E-News /by 3wmedia

Skin tests traditionally used to predict allergies to amoxicillin, one of the most commonly prescribed antibiotics in children, are ineffective according to a new study led by a team at the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal. The findings  determined that oral provocation or challenge test, with appropriate follow up, was a more efficient and safer screening method for diagnosing non-life threatening reactions to amoxicillin in children.

 

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:35Traditional skin tests used to predict allergies to antibiotics are useless

Identifying patients with advanced cervical cancer who may not benefit from bevacizumab

, 26 August 2020/in E-News /by 3wmedia

Patients with advanced cervical cancer who were at intermediate and high risk of poor outcome, as assessed by the Moore criteria, gained survival benefit from having bevacizumab added to their chemotherapy regimen while those at low risk of poor outcome did not, according to results of a major objective of the phase III NRG Oncology-Gynecologic Oncology Group protocol 240 (GOG 240) clinical trial.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:43Identifying patients with advanced cervical cancer who may not benefit from bevacizumab

Biomedical imaging at one-thousandth the cost

, 26 August 2020/in E-News /by 3wmedia

MIT researchers have developed a biomedical imaging system that could ultimately replace a $100,000 piece of a lab equipment with components that cost just hundreds of dollars.

The system uses a technique called fluorescence lifetime imaging, which has applications in DNA sequencing and cancer diagnosis, among other things. So the new work could have implications for both biological research and clinical practice.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:51Biomedical imaging at one-thousandth the cost

Rare form of diabetes may require alternate treatment

, 26 August 2020/in E-News /by 3wmedia

Patients with a rare, genetic form of diabetes often are misdiagnosed as having type 2 diabetes because the two share symptoms.

Washington University School of Medicine
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:38Rare form of diabetes may require alternate treatment

Cancer patient receives 3D printed ribs in world first surgery

, 26 August 2020/in E-News /by 3wmedia

An international collaboration that has led to a world-first in surgery, using a 3D printed titanium sternum and rib implant that was designed and manufactured in Melbourne.
After being diagnosed with a chest wall sarcoma, the 54-year-old man

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:46Cancer patient receives 3D printed ribs in world first surgery

Accuracy of dementia brain imaging must improve

, 26 August 2020/in E-News /by 3wmedia

MRI scans and other tools to detect and diagnose dementia are helpful but not definitive

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:54Accuracy of dementia brain imaging must improve

A ‘fuzzy’ method for interpreting fMRI recordings

, 26 August 2020/in E-News /by 3wmedia

A method for data analysis used in medical diagnostics has been tested for the first time on resting state functional magnetic resonance imaging (fMRI) data. The method, which relies on ‘fuzziness’, proved to be as robust as the well-known and regularly used sample entropy (SampEn) method but with the advantage of offering greater detail than sample entropy.
Do not be misled by the word ‘fuzzy’: Fuzzy Approximate Entropy (fApEn) is a method that offers better sensitivity for understanding the complexity of noisy images produced by functional magnetic resonance imaging (fMRI). fMRI is a medical imaging technique which, when applied to the brain allows non-invasive observation of neural activity associated with specific human behaviour . However, just ‘looking’ at these images is not enough to understand what is going on, and different methods exist that analyse, filter and reconstruct the signals to enable scientists to understand the brain’s complex activity.
fApEn has been used to analyse electrocardiograms, electroencephalograms and
electromyograms, but this is the first time it is used with fMRI because 3D fMRI computation is complex. ‘Until now scientists have preferred to use a reliable method, Sample Entropy (sampEn), which, however, suffers several limitations’, explains Moses Sokunbi, research scientist at the International School for Advanced Studies (SISSA) in Trieste and first author of the study.
‘In this paper we demonstrated not only that fApEn can indeed be used but that compared with sampEn analysis on the same recordings, it gave superior results which were not detected by SampEn ‘.
‘The advantage of fApEn is that it’s a non-linear method’, Sokunbi points out. ‘All too often, in fact, data from the brain are analysed using linear methods, but the brain is a complex system that produces signals that are non-linear and dynamic in nature and analysing with these linear methods results in loss of information ‘.
The non-linear fApEn method was used to test a hypothesis regarding brain activity. ‘ We tested the fMRI data of 86 healthy individuals with age ranging between 19 and 85 years’, explains Sokunbi. ‘The complexity of brain activity is thought to decrease over the years: a young adult brain is more complex than an older adult brain. This hypothesis is supported by several observations so we decided to test it by scanning the brains of individuals of varying age with functional magnetic resonance imaging and analysing the data both with fApEn and SampEn’.
fApEn showed better signal detection in comparison to SampEn. With sampEn there was a tendency in the direction predicted by the hypothesis, but this was not significant. In contrast, fApEn analysis on the same data provided a clear and significant tendency in the expected direction’.

SISSA http://tinyurl.com/zua4jyh

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:32A ‘fuzzy’ method for interpreting fMRI recordings

New light on heart failure

, 26 August 2020/in E-News /by 3wmedia

As part of her PhD study at Maastricht UMC+, internist-in-training Marieke Rienks discovered that three specific proteins play an important role in heart inflammation. This inflammation may be caused by a viral infection and may lead to heart failure. According to Rienks, gaining a better understanding of the inflammatory process can lead to the development of targeted therapies against heart failure.

In addition to viral infections, oxygen deprivation can also damage the heart tissue and lead to heart failure

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:40New light on heart failure
Page 158 of 229«‹156157158159160›»

Latest issue of International Hospital

April 2024

16 May 2025

Mindray launches premium ultrasound system to enhance diagnostic capabilities

15 May 2025

World’s first personalised CRISPR therapy treats child with rare metabolic disorder

14 May 2025

Embedded therapist significantly reduces ICU nurse burnout

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription